Our Initiatives for SDGs
OUR PRACTICES TO ACHIEVE THE SDGs

FY 2022 Annual Activity Report
Introduction
In March 2020, we endorsed the principles of the 'United Nations Global Compact' and announced our participation in it. We then launched internal
activities using the 'Sustainable Development Goals (SDGs)' as an indicator to comply with and put into practice in the principles these activities.Theinitiative, which began in FY2020, has been in progress for threel years, and we are deepening our efforts to achieve the goals through the activities ofeach division.
This report is based on the annual activity reports of each division for FY2022. For each activity, semiannual progress checks and revisions are made torevitalize activities for the year. Since the year before last, we have continued our corporate activities while implementing measures to prevent infection
by the new coronavirus, and have worked to continue stable production of pharmaceutical products. In the future, measures to prevent infection by thenew coronavirus will be eased under the government policy, but we will continue to enhance health promotion for our employees and make this effort a"matter of course" for each and every one of us in response to the principles of the SDGs, aiming to create a better working environment and toimplement stable corporate activities. We also aim to create a better working environment and implement stable corporate activities. In order to realize"efforts to address environmental issues" and "reform of work styles and enhancement of workplace environment" in our daily activities, we believe it isnecessary to aim for corporate activities based on ensuring the health of all employees and the health and safety of the local community, and also taking
into consideration the protection of the global environment.
FUJIMOTO CHEMICALS Co,LTD
ESG Promotion Department
2023年4月28日

1 / 8 ページ

SDGs Activity Goals for FY2022
Target Setting: 10 May 2022
ESG Promotion Department
Goal 3：Good health and Well-being
Business goal：CSR activities via core business・Through our contract manufacturing business of active pharmaceutical ingredients, wemanufacture high-quality pharmaceuticals under cGMP control and contribute to the healthof people around the world through stable supply.
【Division Goals】
Technology Division：Ensure production plans and deadlines are met and maintain a quality assurance system

Research & Development Division：Practicing social contribution through drug development

Administration Division：Ensure compliance with laws and regulations and revitalize the company

Sales Division：Increase customer satisfaction

Goal 7：Aﬀordable and Clean energy
Business Goal：Promoting energy conservation
・Reduce energy consumption based on energy base unit.
・Promote the introduction of low-GHG (Greenhouse gas) equipments and devices.
【Division Goals】
Technology Division：Practicing environmental measures through ISO 14001 andenergy-saving activitiesResearch & Development Division：Contribution to pharmaceutical manufacturing with reduced environmental impact

Administration Division：Transition to New Normal Digital Management

Sales Division：Improving the eﬃciency of sales activities
2/8

Goal 8：Decent work and Economic growthBusiness Goal：Respect for human rights and compliance with laws and regulations through businessactivities
・Achieve revitalization of the organization by promoting work style reforms.
・Use in-company human resources eﬃciently and systematically recruit employees, looking aheadto the future.
・Strengthen the CSR procurement throughout the supply chain.
【Division Goals】
Technology Division： Reduce overtime and workload

Research & Development Division： Execution of an ongoing training system and participation in conferences and workshops

Administration Division： Recruitment in line with company strategy

Sales Division： Strengthening communication skills

Goal 9：Industry, Innovation and Infrastructure
Business Goal：Commercialization of nucleic acid pharmaceutical business
Solid phase synthesis has been established as a manufacturing method for nucleic acid drugs which are expected tobe applied to rare diseases. We have newly developed a carrier (Fujimat🄬) for liquid-phase synthesis instead whichenables inexpensive mass production of nucleic acid drugs. The technology is expected to accelerate thedevelopment of new nucleic acid drugs. After its launch, we hope to establish an integrated supply system forpharmaceuticals serving the world under our GMP management.
【Division Goals】
Technology Division
Research & Development Division
Administration Division
Sales Division

ー：Contribution to pharmaceutical manufacturing through the development of new technologies
ー：Dissemination of information on our technology
3/8

Goal 12：Responsible consumption and Production
Business Goal：Risk management, Promote crisis management, Reduction in raw materials usage,
Enhanced recycling, Development of environmentally friendly manufacturing methods
・Reduce energy consumption by promoting the stable procurement of raw materials and conducting
the planned production.
・Reduce usage of harmful substances and strengthen the management of harmful substances in products.
・Promote recycling of organic solvents.
・Promote reduction of processes and raw materials by improvement of manufacturing methods.
【Division Goals】
Technology Division：Compliance with laws and regulations related to chemical substances, waste
reduction, and recycling promotion

Research & Development Division：Promote initiatives through manufacturing process optimization studies

Administration Division：Promote CSR and risk managemen

Sales Division：Multiple sources of key raw materials and establishment of new technologies

Goal 14：Life below water
Business Goal：Industrial wastewater management
・Complete management of the facilities of activated sludge process. Achieve the regulated value oftreated wastewater for release to the Osaka Bay.
・Completer wastewater management for sewage.
・Complete control of the processing method of industrial waste generated from the facilities for highpotency active pharmaceutical ingredient.
【Division Goals】
Technology Division：KYK Used Tare and Industrial Wastewater Management

Research & Development Division：Acquire knowledge of industrial wastewater management and water quality control

Administration Division
Sales Division

ー：Eﬀective utilization of industrial waste
4/8

Technology Division Action Targets/Progress
Action Items

Targets

SGD Goal

Status of Achievment

Senboku

Stable production of CA and FeAchieve the planned quantity of goods

Goal 3just as planned

100%

Plant

Introduction of milling process for S product (establishment of system toPV completedGoal 3

To be implemented in the next fiscal year (not－Completion of technology transferGoal 3

increase S production).
Transfer of S-process technology(establishment of system to increase S

Progressevaluated)

production).

Contractor PV completed and technology transfer

100%

completed.

Achievement of "zero" complaints

0 cases

Goal 3

2 quality complaints occurred.

Introduction of environmentally friendly equipments

One or more

Goal 7

1 equipment introduced

100%

0%
100%

Reduction of electricity consumption

0.1% reduction

Goal 70.1%

Workload reduction by appropriate workforce planning and recruitments

75% or less operation rate

Goal 877.7%

0%Accident/disaster-free operations

0 caseGoal 120 case

100%

Resource and energy savings by solvent recycling and other measures

1 case or more

Goal 12

1 case conducted100%

Thorough management of used containers for pharmacologically active

No exposure incident

Goal 140 case

100%

Compliance with regulated standards

Goal 14Compliance achieved

100%

Study of changes for each item

Goal 3

Confirmation of change of manufacturer (use test) of

100%

materials
Trend analysis of activated sludge treatment through daily monitoring andimplementation of countermeasures

KinrakuContinued production of P products

Plant

・Consideration of supplier change for diﬃcult -to-procure materials

raw materials A, B and C has been completed.

・Change of manufacturer of raw material A, 2 raw material B, raw material C.

Monomer production capacity enhancement

Tech-transfer of OH-form

Goal 3Tech-transfer of T-form

OH-form tech-transfer completed.

100%

T-form tech-transfer completed;1 lot manufactured.

Achievement of "zero" complaints

0 cases

Goal 3

one quality complaints occurred.

Introduction of environmentally friendly equipments

three or more

Goal 7

3 equipments introduced

100%

0%

Reduction of electricity consumption

0.2% reduction

Goal 70.26％ reduced

100%

Improvement of labor productivity

70% or less operation rate

Goal 8

Production activities ceased due to raw material－supply disruptions.(Not rated)
Accident/disaster-free operations

zero accident

Goal 120 case

Wastes recycling

One or more cases

Goal 120 case

100%

Daily monitoring and weekly water quality testing

Compliance with regulated standards

Goal 14Compliance achieved

100%CMC

Ensure implementation of capital investment plans to increase plant

New administration building project

Goal 3

Construction output as planned (as at end- March)

100%

Planning

productivity

implementation.

Department

Implementation of environmental activities through ISO14001 and energy saving
Zero finding at JQA audit

Goal 70 case

100%・Promotion of energy-saving activities

1% reduction of energy intensity

Goal 7

3.1% reduction from the previous fiscal year

100%Compliance with Chemical Substance Related Regulations

Compliance with Chemical Substances

Goal 12

respond in full

100%

Goal 120%

activities
・Promotion of ISO14001 activities

Control and Industrial Safety and Health
Promotion of EHS activities
Quality

Execution of planned supplyer audits

Zero accicent/disaster（both plants）

0 case (1 case by the constructor).

100%

Zero environmental accident (both plants) Goal 14

0 case100%

21 audits planned

42 audits executed

100%Assurance
Department
5/8

Goal 3

Research and Development Division Action Targets/Progress
Action Items

Targets

SDG Goal Remarks

Status of Achievement

Progress

Against FY2030 Targets
Research and・Contract manufacturing of products underDevelopment

development

Division・Scale-up study

90 cases : 2030

・No overtime work for all employees

90 products : 2030 Goal 3

Current year (+last year)
3 products (+6 products)

10%

Goal 76 cases (+7)

14%

120 times : 2030

Goal 7

12 times (+12)

20%

・Participation in conferences and workshops

150 cases : 2030

Goal 830 cases (+42)

48%

・Study of new technology development

30 cases : 2030

Goal 93 cases (+5)

27%・Study of manufacturing method improvement 30 cases : 2030

Goal 128 cases (+7)

50%

・Zero TOC abnormality in waste water

Goal 14No abnormality for two

20%

100% : 2030

years
・Study sessions on water quality

10 sessions : 2030 Goal 14

1 session (+1)

20%

Against FY2022 targets
Process・Contract manufacturing of products underDevelopment

development

Laboratory

9 products : 2022

Goal 33 products

33%

・Scale-up study

9 cases : 2022

Goal 7

6 cases67%

・No overtime work for all employees

12 times : 2022

Goal 7

conducted jointly 12 times

100%

・Participation in conferences and workshops

8 cases : 2022

Goal 818 cases

100%

・Improvement of manufacturing process

3 cases : 2022

Goal 128 cases100%

・ Zero TOC abnormality in waste water

100% : 2022

Goal 14conducted jointly No abnormality

100%

・Study sessions on water quality

1 session : 2022

Goal 14conducted jointly 1 session

100%

Basic Technology ・No overtime work for all employees

12 times : 2022

Goal 7

conducted jointly 12 times

100%

Debelopment

・Participation in conferences and workshops

7 cases : 2022

Goal 820 cases100%

Laboratory

・Study of new technology development

3 cases : 2022

Goal 93 cases in progress

100%

・Zero TOC abnormality in waste water

100%: 2022

Goal 14conducted jointly No abnormality

100%

・Study sessions on water quality

1 session : 2022

Goal 14conducted jointly 1 session

100%

6/8

Administration Division Action Targets/ Progress
Action Items

Targets/ GoalsSDG Goal Remarks

Status of Achievement

Administration Transformation intoBPR efforts for core business systems Goal 7OBIC

Payroll cloud and core accounting information is being

Division

an Ecosystem(DX)

100%

SMILE

collected.

Realization ofPromote electronic stamping andXPOINT

Electronic contracting for new administration building

futuristic officeelectronic contracting 100%
Sales accounting and payroll office

Goal 8Cloud Sign
Goal 8Recruitment

Hiring of 22 new graduates and mid-50%
60%

implemented; cloud billing system (Bill One) alreadyinstalled.
Consolidation of administrative departments to the 3rd

centralization 100%Progress100%

floor of the head office.
Goal 824 new

Employed manufacruring 14、QC 8、R&D 2、sales 2.

careers

graduates hired(manufacruring 11、QC 5、R&D 4、

2 mid-career

sales 2sales 2)

A total of 26

Continued mid-career hiring for QA and manufacturing

100%

were hired
BCP review

Company-wide BCP drill

Goal 12Company-wide training conducted on 8/18

100%

Update of BCP documentation

Goal 12Update work completed and distributed to each site in100%

Nov.
Through complianceUtilization of paid holidays aswith laws andrequired by lawregulations

Overtime work management

Goal 3Completed by informing employees who have taken

100%

less than five days of paid holiday.
Goal 3Monthly overtime totals reported to each site.

(strict adherence to 36 agreement）

100%

No violation of 36 agreements.

Promoting Male Maternity holiday

Goal 38 employees acquired in FY2022.

100%

revitalization activities Conducted employee satisfaction

Goal 3

Conducted in conjunction with stress checks.

100%

Goal 3

Certified in March.

100%

KDDI leased

TEAMS telecommunications network at head office

100%

line

completed.

TEAMS

Improved environment and better calling environment.

Companysurvey
Certified as an excellent healthmanagement corporation
DX to New Normal

80 % of internal meetings to bemanagementtransferred to web meetings

Goal 7

7/8

Sales Division Action Targets/ Progress

Sales

Progress

Action Items

Targets

SDG Goal Remarks

Status of Achievement

Customer survey

3 surveys

Goal 3

2 surveys

66%

1 case (thorough green procurement of consumables)

100%

Daily reports, young employee presentations

100%

Division Promote energy-saving activities 1 case

Goal 7

Green Procurement
Promotion

Study group

Information Sharing

Goal 8and Skills up
Nucleic Acid Commercialization

Themes acquiredand Production System(3 cases)

conducted
Goal 93 cases (Fujimat🄬 sales, Fujimat🄬 use with Company

66%

S contract signed for use, Capping Reagent forDevelopment

Company A)

Expansion of initial development 5 cases

Goal 93 cases60%

products and Introduction of highpharmacological products
Stable supply of existing

5 cases

Goal 12 Product A, Product Fe, Product A: n-BuLi compatible.

products

100%

Product G,Product CA, Product Fe: Progress management by regular meeting.
Product S

Product G: Forecast confirmation.
Product CA: Confirmation of future trends byconfirming the client's business strategy.
Product S: Ensure customer schedules and production
systems.

Establishment of flow synthesis

P Company and other Goal 9

5 cases or more(P Company made presentations toinfrastructure

CDMOs Confirmation

pharmaceutical companies)

100%of activities(5 cases)
New material and product12 cases

Goal 12 Trading company

development

8 cases(proposals for electronic materials materials)

66%functions and Product 0 case cosmetics related
HA inducements New
cosmetic materials

Stable procurement of raw

5 cases

Goal 12 5 major products

Listed one company for purchase and began research50%

1 caseGoal 142 cases (iodine, Pd recovery study)

100%materials
Effective utilization of waste
liquid8/8